22 related articles for article (PubMed ID: 4847775)
1. Antimetabolites produced by microorganisms XVI. Synthesis of N5-hydroxy-2-methylarginine and N5-hydroxy-2-methylornithine.
Maehr H; Leach M
J Antibiot (Tokyo); 1978 Mar; 31(3):165-9. PubMed ID: 649511
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of allose-templated hydroxyornithine and hydroxyarginine analogs.
Mondal D; Schweizer F
Carbohydr Res; 2010 Jul; 345(11):1533-40. PubMed ID: 20478556
[TBL] [Abstract][Full Text] [Related]
3. Antimetabolites produced by microorganisms. XV Synthesis of 2-methyl-L-arginine, 2-methyl-L-ornithine and their enantiomers.
Maehr H; Yarmchuk L; Leach M
J Antibiot (Tokyo); 1976 Mar; 29(3):221-6. PubMed ID: 1262253
[TBL] [Abstract][Full Text] [Related]
4. Antimetabolites produced by microorganisms. VI. L-N 5 -(1-iminoethyl) ornithine.
Scannell JP; Ax HA; Pruess DL; Williams T; Demny TC
J Antibiot (Tokyo); 1972 Mar; 25(3):179-84. PubMed ID: 5034813
[No Abstract] [Full Text] [Related]
5. Synthesis and properties of -N-hydroxyornithine.
Tomlinson G; Viswanatha T
Can J Biochem; 1973 Jun; 51(6):754-63. PubMed ID: 4717061
[No Abstract] [Full Text] [Related]
6. N-hydroxylation.
Uehleke H
Xenobiotica; 1971; 1(4):327-38. PubMed ID: 4950820
[No Abstract] [Full Text] [Related]
7. [Problems of nucleoside antimetabolites].
Wagner G
Pharmazie; 1971 Jul; 26(7):377-87. PubMed ID: 4937587
[No Abstract] [Full Text] [Related]
8. New trends in synthesis of pyrazole nucleosides as new antimetabolites.
Elgemeie GH; Zaghary WA; Amin KM; Nasr TM
Nucleosides Nucleotides Nucleic Acids; 2005; 24(8):1227-47. PubMed ID: 16270665
[TBL] [Abstract][Full Text] [Related]
9. Antimetabolites produced by microorganisms. IX. Chemical synthesis of N5-hydroxyornithine and N5-hydroxyarginine.
Maehr H; Leach M
J Org Chem; 1974 Apr; 39(8):1166-8. PubMed ID: 4847775
[No Abstract] [Full Text] [Related]
10. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids.
Weisburger JH; Weisburger EK
Pharmacol Rev; 1973 Mar; 25(1):1-66. PubMed ID: 4571258
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
